Literature DB >> 11095858

Gram-Positive Pneumonia.

.   

Abstract

Gram-positive pneumonia is a leading cause of morbidity and mortality throughout the world. Of the gram-positive pathogens that cause pneumonia, Streptococcus pneumoniae and Staphylococcus aureus are the most common. The diagnosis of gram-positive pneumonia remains less than satisfactory, and newer diagnostic techniques such as antibody- and polymerase chain reaction-based antigen detection have yet to prove themselves. Drug resistance among gram-positive organisms is now endemic throughout the world and remains a serious therapeutic problem despite the availability of new antimicrobials. Efforts to control the spread of resistant strains include, in the case of S. aureus, stringent isolation policies and topical treatment to reduce carriage and, for S. pneumoniae, increased use of available vaccines and the develop- ment of more immunogenic vaccines.

Entities:  

Year:  2000        PMID: 11095858     DOI: 10.1007/s11908-000-0037-5

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  52 in total

1.  Fluoroquinolone resistance in Streptococcus pneumoniae.

Authors:  J Liñares; A G de la Campa; R Pallares
Journal:  N Engl J Med       Date:  1999-11-11       Impact factor: 91.245

2.  Bacteremic pneumococcal pneumonia in one American City: a 20-year longitudinal study, 1978-1997.

Authors:  M A Mufson; R J Stanek
Journal:  Am J Med       Date:  1999-07-26       Impact factor: 4.965

3.  A randomized, crossover design study of the pharmacology of extended-spectrum fluoroquinolones for pneumococcal infections.

Authors:  G W Amsden; D M Graci; L J Cabelus; L G Hejmanowski
Journal:  Chest       Date:  1999-07       Impact factor: 9.410

4.  Protective immunity of microsphere-based mucosal vaccines against lethal intranasal challenge with Streptococcus pneumoniae.

Authors:  S Y Seong; N H Cho; I C Kwon; S Y Jeong
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

5.  Emergence of vancomycin tolerance in Streptococcus pneumoniae.

Authors:  R Novak; B Henriques; E Charpentier; S Normark; E Tuomanen
Journal:  Nature       Date:  1999-06-10       Impact factor: 49.962

Review 6.  Invasive pneumococcal infections: incidence, predisposing factors, and prognosis.

Authors:  L A Burman; R Norrby; B Trollfors
Journal:  Rev Infect Dis       Date:  1985 Mar-Apr

7.  Pneumolysin PCR-based diagnosis of invasive pneumococcal infection in children.

Authors:  P Toikka; S Nikkari; O Ruuskanen; M Leinonen; J Mertsola
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

8.  Invasive pneumococcal disease in central Australia.

Authors:  J Trotman; B Hughes; L Mollison
Journal:  Clin Infect Dis       Date:  1995-06       Impact factor: 9.079

9.  Pneumococcal bacteremia at a medical/surgical hospital for adults between 1975 and 1980.

Authors:  F L Ruben; C W Norden; Y Korica
Journal:  Am J Med       Date:  1984-12       Impact factor: 4.965

10.  Minimizing the impact of drug-resistant Streptococcus pneumoniae (DRSP). A strategy from the DRSP Working Group.

Authors:  D B Jernigan; M S Cetron; R F Breiman
Journal:  JAMA       Date:  1996-01-17       Impact factor: 56.272

View more
  3 in total

Review 1.  Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.

Authors:  Steven Y C Tong; Joshua S Davis; Emily Eichenberger; Thomas L Holland; Vance G Fowler
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

2.  Gene expression analysis for pneumonia caused by Gram-positive bacterial infection.

Authors:  Rufu Jia; Jingyan Yang; Ying Cui; Dongjie Guo; Tiejun Li
Journal:  Exp Ther Med       Date:  2018-02-28       Impact factor: 2.447

3.  E3 ligase subunit Fbxo15 and PINK1 kinase regulate cardiolipin synthase 1 stability and mitochondrial function in pneumonia.

Authors:  Bill B Chen; Tiffany A Coon; Jennifer R Glasser; Chunbin Zou; Bryon Ellis; Tuhin Das; Alison C McKelvey; Shristi Rajbhandari; Travis Lear; Christelle Kamga; Sruti Shiva; Chenjian Li; Joseph M Pilewski; Jason Callio; Charleen T Chu; Anuradha Ray; Prabir Ray; Yulia Y Tyurina; Valerian E Kagan; Rama K Mallampalli
Journal:  Cell Rep       Date:  2014-04-03       Impact factor: 9.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.